Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : NBMX - National Boston Medical (was FGRX) -- Ignore unavailable to you. Want to Upgrade?

To: Joe Copia who wrote (773)	11/3/1998 10:02:00 AM
From: Blitz	Read Replies (1) \| Respond to of 1286

News... (BSNS WIRE) National Boston Medical Inc. Today Announces Product Approva National Boston Medical Inc. Today Announces Product Approval, Launches Business Editors/Health & Medical Writers POMPANO BEACH, Fla.--(BW HealthWire)--Nov. 3, 1998--National Boston Medical (OTC BB:NBMXD) is pleased to announce it has completed development of its new series of VERTA infection control product for use in dental offices. The company has now received approval from the appropriate regulatory agency's of the following products for sale in the US and Canada. The launch of the VERTA series concludes many months of research and development to develop and acquire products, which will position NBM as the leader in the fight against cross contamination. Today's product launch includes the VERTA LINE, VERTA VAC, and VERTA SON. VERTA LINE protects patients from cross contamination and Bacterial Aerosols, and eliminates Pseudomontis and Psudoaerugenosa from self-contained dental water devices. VERTA VAC is a uniquely newly developed Bio-Formulation consisting of a synergistic blend of selected activity resulting in a breakdown of tissues, oil, blood, and organic matter in dental evacuation systems. The third product, VERTA SON, was developed for pre-soaking dental instruments to remove blood, and organic matters minimizing the need to hand clean instruments. These products expand on or replace technology presently in use in dental practice today. Dental practices today are becoming more aware of cross contamination as technology and research identify true residual effect of cross contamination. President, Dan Hoyng stated: "The VERTA series is a wonderful compliment to the SafeShield(tm) germicidal skin protectant and Bontempi medical instrument line. This product launch maximizes revenue potential for the account managers with minimal cost increases to NBM. The VERTA series further strengthens NBM position in the still developing billion dollar industry of anti-microbial products." Hoyng further stated that NBM is committed to continue further research and development and acquisitions to expand its infection control product line. --30--cp/mi* CONTACT: Baron Marney Capital 1-800-680-4744 KEYWORD: FLORIDA INDUSTRY KEYWORD: ENMED ENVIRONMENT MEDICINE PRODUCT Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. URL: businesswire.co * end of story * P.S. WHY IS THE BARON'S NAME AND # STILL ON THE PRS????????? THIS COMPANY BETTER GET IT'S ACT TOGETHER!!!!